Drinane Juliana Papa 4

What Happened Juliana Drinane, Interim Head of Manufacturing & Supply at Organon (OGN), received a new award of 125,208 restricted stock units (RSUs) on March 31, 2026. Two earlier RSU grants vested on the same date (6,378 and 10,073 shares); those vested RSUs were converted to shares and a total of 5,636 shares were surrendered to cover tax withholding at $5.70 per share (total withholding ≈ $32,126). The new 125,208 RSU award vests in three equal installments on March 31 of 2027, 2028 and 2029 (each RSU represents one share).

Key Details

• Transaction date: March 31, 2026. Tax withholding price used: $5.70 (Organon closing price on March 30, 2026).
• New award: 125,208 RSUs granted (A); implied market value at $5.70 ≈ $713,686 (award reported at $0 in Form 4 as an equity grant).
• Vested/converted RSUs: 6,378 and 10,073 RSUs converted to shares (M), then 2,185 and 3,451 shares were withheld for taxes (F) for a total withheld of 5,636 shares (~$32,126).
• Shares owned after transaction: not specified in the provided filing.
• Notable footnotes: withholding price per share is plan-required closing price (F1); the 125,208 RSUs vest in three equal annual installments 2027–2029 (F2, F3); the vested conversions relate to prior grants from 2023 and 2025 (F4, F5).
• Filing timeliness: no late filing indicator provided; filing dated April 2, 2026 for transactions on March 31, 2026.

Context

• These transactions are mainly an award (grant of RSUs) plus routine tax withholding when earlier RSUs vested. The conversion entries (M) at $0 reflect RSU vesting/conversion to shares rather than a cash purchase. The withheld shares are a common "sell/withhold-to-cover" mechanism to meet tax obligations and do not necessarily indicate a directional view on the stock.